Answers are grounded in this paper and cite their sources.
As demand for sustainable nanotechnology grows, microbial synthesis has emerged as an environmentally friendly alternative to conventional nanoparticle production methods. Microorganisms, including bacteria, fungi, algae, cyanobacteria, and actinomycetes, can synthesize metallic, metal oxide, and hybrid nanomaterials through enzymatic and metabolite-mediated pathways. Unlike conventional physicochemical approaches, microbial synthesis generally operates under mild conditions and reduces the reliance on hazardous chemicals and energy-intensive processes. These biologically synthesized nanomaterials exhibit excellent biocompatibility, enhanced surface functionality, and reduced environmental impact, making them attractive for biomedical, environmental, and industrial applications. This review comprehensively discusses recent advances in microbial nanomaterial biosynthesis and functionalization, and their applications in antimicrobial therapy, cancer treatment, wound healing, drug delivery, wastewater treatment, pollutant degradation, biosensing, food packaging, and sustainable catalysis. It also highlights current challenges, including reproducibility, process optimization, scale-up, and regulatory acceptance, that limit large-scale commercialization. A key focus of this review is the emerging integration of artificial intelligence (AI), machine learning (ML), and data-driven materials informatics with microbial nanotechnology. These computational approaches enable predictive modeling, synthesis optimization, high-throughput screening, intelligent functionalization, process control, and safety assessment. Consequently, they can reduce experimental effort and accelerate nanomaterial discovery. Finally, the review discusses future opportunities arising from the convergence of microbial biotechnology, AI, automation, and synthetic biology. This integration could enable autonomous, self-optimizing nanomanufacturing platforms for the production of next-generation bio-based nanomaterials.
No takes yet. Share an insight, caveat, or question.
Salim et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: